Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does not look good. If nasdaq uplisting gets rejected this stock will suffer a lot. Let's see. Still Long !!
All blue sky. $0.50 by year end.
NSPR heavily undervalued. $3 stock atleast.
dump dump dump , all I can say about this pos
NBEV = new TLRY !!
Lots of headwind.. will fly after Q3 earning.
NBEV to $50 ... loading all I can !!
Time to Fly. Approval in US by Q2 2019?
CBD-drink = fastest growing sector in the world
Close $0.15 would be nice
Could hit $1.00 easy,CBD-beverage is hottest sector now
$10 by Q2-2019. Chances of Approval very high. IMO
Will fly like AMRN by Q2 2019. IMO
GTF ..could you please provide the link or post the numbers. I can't find.
Beverage = poor margin. CVSI = real winner.
IGC seems to me a Scam, NBEV is real company with real CBD beverage product lines. But keep in mind beverage business is a very low profit margin business especially for the small companies like NBEV, NBEV not profitable yet. In contrast CVSI is a highest quality CBD oil manufacturer and it's a highly profitable business. Every CBD beverage needs CBD Oil , not only that CBD oil moving at fast pace in health care for various indications. That's why CVSI will be a major winner. I am holding with patience. More it goes down before recovery better for long term investors. I don't think it will recover before Q3 earning, good for those who are looking for a long term entry. I'm long at $1.32.
Newbie here: How much was Q2 revenue?
I read the PR and it says 600% growth but it does not mention total Q2 revenue.
$1.50 next week. Wild ride ahead.
CVM Phase-3 not complete - high risk. CRMD phase-3 stopped on efficacy, approval and commercialization by Q2 2019 most likely. CRBSI is a major problem in hospitals and clinics.. CRMD could pull $1B annual sales. CRMD = low risk high reward opportunity.
FDA meeting in Q4, approval by Q2 next year IMO. Huge untapped market with unmet medical need, billion dollar annual sales potential from Neutrolin alone.
Need some patience here. Short term rally over, it will move again after Q3 earning report.
Time to Fly !!
closing between $5.75 and $6
$15 after October 8th CBD-Beverage launch.
Next PR could be :"Entering Into Cannabis farming in the US". This is a scam in my opinion
Taking a support at low $4. Will make big move soon.
Might be a Scam !!
Just look at the business profile .. infrastructure, road, equipment rental to Cannabis for Alzheimer, Parkinson and lately CBD infused beverage partnership. No mention of who is the partner. NBEV is true CBD infused beverage company, has real products, launch on October 8th. This POS has such a diverse business portfolio I think PR coming soon that they will be doing steel manufacturing in US as Trump imposed tariffs ..ha ha ha !! All these fluffy PRs indicate this is a scam IMHO
Shortterm Target $8
Major breakout around the corner.
CGuard™ Embolic Prevention System (EPS) currently not approved in US for sale. Even though CGuard EPS sales are flying at high double digit growth rate, that's the underlying reason the stock price is so low. They have met FDA already and will submit investigational device exemption (IDE) for CGuard™ EPS by Q2 2019. The stock is trading at very high volume since past few days and I bet big boys taking early bird loadings. Once IDE is submitted to FDA this stock will fly. Has all ingredients to be a billion dollar company.
Big boys loading.. $1 soon
Chart is all set for a big breakout. May be tomorrow.
This stock is severely undervalued. Should trade at $3+
You can't compare CVSI to GOOG and FB... makes no sense. Law suits are hurting this stock because it's a small OTC company and thus investors losing trust fast and also cannabis sector is highly volatile.
If no patent controversy, CVSI would be $15 now.
CRMD could be a billion dollar company upon approval. Large marker, unmet medical need and no solution.
Any update on Farm Bill 2018?
Entire Cannabis sector getting dumped and we see non-stop lawsuits are coming against CVSI.
last chance to get under $5, $50 by mid 2019 IMO
Close $7+ today. $20+ by October 8-th.
Load the morning pullback, gonna explode this week.
NBEV: in Full Bull Mode $20 ahead
1. CBD infused product lines - tested for safety and entertainment. Ready to be launched. 8th October is vital date and a huge bullish date.
2. Stock trades based on future not current
3. CBD is fasted growing sector in the world at this time.